Renal cell carcinoma with metastases to the external genitalia. Literature review and case report

Renal cell carcinoma with metastases to the external genitalia. Literature review and case report

Annually, up to 300 thousand new cases of kidney cancer and more than 134 thousand deaths associated with this disease are registered in the world. In the Russian Federation in 2019, 20,758 patients with a newly diagnosed renal cell carcinoma were registered; it should be noted that at the end of 20...

Full description

Bibliographic Details
Main Authors:	K. V. Menshikov, A. V. Sultanbaev, Sh. I. Musin, A. A. Izmaylov, R. R. Muginov, I. A. Menshikova, I. A. Sharifgaleev, D. O. Lipatov, N. I. Sultanbaeva
Format:	Article
Language:	Russian
Published:	ABV-press 2021-07-01
Series:	Onkourologiâ
Subjects:	renal cell carcinoma metastasis to the external genital organs sanitation vulvectomy palliative nephrectomy tyrosine kinase inhibitor cabozantinib
Online Access:	https://oncourology.abvpress.ru/oncur/article/view/1469

Similar Items

Current Techniques for Detecting Sentinel Lymph Nodes in Vulvar Cancer
by: Sh. Kh. Gantsev, et al.
Published: (2019-03-01)

Surgical treatment of vulvar cancer in patients with concomitant disorders
by: A. A. Mukhin, et al.
Published: (2020-03-01)

The Use of Cabozantinib in Advanced Hepatocellular Carcinoma in Hong Kong—A Territory-Wide Cohort Study
by: Jeffrey Sum-Lung Wong, et al.
Published: (2021-04-01)

Possibilities of Surgical Treatment of Vulva Cancer in the Context of the COVID-19 Pandemic
by: Sh. Kh. Gantsev, et al.
Published: (2020-12-01)

Neoadjuvant Cabozantinib in an Unresectable Locally Advanced Renal Cell Carcinoma Patient Leads to Downsizing of Tumor Enabling Surgical Resection: A Case Report
by: Mehmet A. Bilen, et al.
Published: (2021-02-01)

Vulvar carcinoma: dilemma, debates, and decisions
by: Mitra S, et al.
Published: (2018-01-01)

Activity of cabozantinib in radioresistant brain metastases from renal cell carcinoma: two case reports
by: Sylvie Négrier, et al.
Published: (2018-11-01)

Minimal vulvar cancer: a literature review and own observations
by: A. A. Il’in, et al.
Published: (2018-10-01)

Real-Life Clinical Data of Cabozantinib for Unresectable Hepatocellular Carcinoma
by: Francesco Tovoli, et al.
Published: (2021-06-01)

Renal cell carcinoma: An update for the practicing urologist
by: Sumanta K. Pal, et al.
Published: (2015-01-01)

Possibility of reconstruction after surgical treatment for giant Buschke–Löwenstein condyloma
by: A. A. Mukhin, et al.
Published: (2021-06-01)

Profile of Cabozantinib for the Treatment of Hepatocellular Carcinoma: Patient Selection and Special Considerations
by: Debaillon Vesque A, et al.
Published: (2020-06-01)

Surgical management of squamous cell vulvar cancer without clitoris, urethra or anus involvement
by: Alpaslan Kaban, et al.
Published: (2017-05-01)

Atypical Posterior Reversible Encephalopathy Syndrome due to Oral Tyrosine Kinase Inhibitor Cabozantinib: First Case Report
by: Anannya Patwari, et al.
Published: (2020-08-01)

A retrospective review of the multidisciplinary management of medullary thyroid cancer: eligibility for systemic therapy
by: Georgia Geller, et al.
Published: (2017-09-01)

A rare case of vulvar squamous cell carcinoma; case presentation
by: Cristina N. Cozma, et al.
Published: (2018-05-01)

Interdisciplinary treatment of the patient with adenoid cystic carcinoma of the Bartholin’s gland resulting in 15 years’ survival: a case report and review of literature
by: Marek Nowak, et al.
Published: (2014-11-01)

Cabozantinib in Advanced Hepatocellular Carcinoma: Efficacy and Safety Data from an International Multicenter Real-Life Cohort
by: Fabian Finkelmeier, et al.
Published: (2021-06-01)

Control of renal cell carcinoma brain metastases with cabozantinib following progression on immune checkpoint inhibitor therapy
by: Cierra Hong, et al.
Published: (2021-03-01)

Identification of Enzymes Oxidizing the Tyrosine Kinase Inhibitor Cabozantinib: Cabozantinib Is Predominantly Oxidized by CYP3A4 and Its Oxidation Is Stimulated by cyt b<sub>5</sub> Activity
by: Radek Indra, et al.
Published: (2020-11-01)

Practical management of adverse events associated with cabozantinib treatment in patients with renal-cell carcinoma
by: Gerendash BS, et al.
Published: (2017-10-01)

Continent cutaneous diversion and external genitalia reconstruction in a child with severe variety urogenital sinus and ambiguous genitalia
by: Sajni I Khemchandani
Published: (2015-01-01)

Secondary healing strategy for difficult wound closure in invasive vulvar cancer: a pilot case-control study
by: Altamiro Ribeiro Dias-Jr, et al.

Prognosis of vulval cancer with lymph node status and size of primary lesion: A survival study
by: Pankaj Deka, et al.
Published: (2014-01-01)

Case Report: Biologic graft placement with subsequent radiation therapy following radical vulvectomy for adenoid cystic carcinoma of the Bartholin’s gland
by: Keely Ulmer, et al.
Published: (2021-05-01)

A Durable Response With the Combination of Nivolumab and Cabozantinib in a Patient With Metastatic Paraganglioma: A Case Report and Review of the Current Literature
by: Minas P. Economides, et al.
Published: (2020-11-01)

Vandetanib versus Cabozantinib in Medullary Thyroid Carcinoma: A Focus on Anti-Angiogenic Effects in Zebrafish Model
by: Silvia Carra, et al.
Published: (2021-03-01)

Regression of Intracranial Meningiomas Following Treatment with Cabozantinib
by: Rupesh Kotecha, et al.
Published: (2021-04-01)

Gracilis myocutaneous flap for perineal defect reconstruction after left hemivulvectomy for locally invasive vulvar cancer – A case report and a literature review
by: Nicolae Bacalbasa, et al.
Published: (2019-05-01)

Correlação entre Estadiamento Clínico e Cirúrgico de Pacientes com Carcinoma Invasor da Vulva Correlation between Clinical and Surgical Staging of Patients with Invasive Vulvar Carcinoma
by: Angelo do Carmo Silva Matthes, et al.
Published: (1999-10-01)

Total Infralevatorian Exenteration with Vulvectomy as Salvage Therapy in a Recurrent Irradiated Cervical Cancer with Pelvic Sidewall Involvement
by: Bécsi János, et al.
Published: (2017-03-01)

Mini-Review: Cabozantinib in the Treatment of Advanced Renal Cell Carcinoma and Hepatocellular Carcinoma
by: Rathi N, et al.
Published: (2020-05-01)

Neuroendocrine Tumours: a Literature Review
by: K. V. Menshikov, et al.
Published: (2021-05-01)

Clinical experience in using sorafenib in patients with advanced kidney cancer
by: A. V. Zyryanov, et al.
Published: (2017-06-01)

: Frequency of human papilloma virus genotypes Among woman with genitalia lesion , Sanandaj ,Iran
by: K. Hajibagheri, et al.
Published: (2018-09-01)

Cabozantinib as the causative agent of high-grade fever in a patient with a background of metastatic clear cell renal cell carcinoma: a case report
by: H. M. N. Chen, et al.
Published: (2020-11-01)

Antitumor Effect of Cabozantinib in Bone Metastatic Models of Renal Cell Carcinoma
by: Michele Iuliani, et al.
Published: (2021-08-01)

Caracterização histopatológica e imuno-histoquímica de neoplasmas mesenquimais da genitália em 43 cadelas Histopathological and immunohistochemical characterization of mesenchymal neoplasms of the genitalia in 43 bitches
by: Suyene O. de Souza, et al.
Published: (2012-12-01)

De morseir syndrome presenting as ambiguous genitalia
by: Anubhav Thukral, et al.
Published: (2012-01-01)

Self Mutilation of Genitalia-Using Teeth
by: Ugur Lok, et al.
Published: (2014-02-01)